Susceptibility of group A beta-hemolytic streptococci to thirteen antibiotics: Examination of 301 strains isolated in the United States between 1994 and 1997

Pediatric Infectious Disease Journal

Volumn 18, Issue 12, 1999, Pages 1069-1072

  Kaplan, Edward L ^a   Johnson, Dwight R ^a   Del Rosario, Maria Concepcion ^a   Horn, David L ^b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Antibiotic susceptibility; Etest; Group A streptococci

Indexed keywords

ANTIBIOTIC AGENT; AZITHROMYCIN; CEFALOTIN; CEFTRIAXONE; CHLORAMPHENICOL; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; IMIPENEM; LEVOFLOXACIN; MACROLIDE; OXACILLIN; PENICILLIN G; TETRACYCLINE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CONTROLLED STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; STRAIN DIFFERENCE; STREPTOCOCCUS GROUP A; UNITED STATES;

EID: 0032761026     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-199912000-00008     Document Type: Article

References (22)

1. Bisno AL, Gerber MA, Gwaltney JMJ, et al. Diagnosis and management of Group A streptococcal pharyngitis: a practice guideline. Clin Infect Dis 1997;25:574-83.
2. Macris MH, Hartman N, Murray B, et al. Studies of the continuing susceptibility of group A streptococcal strains to penicillin during eight decades. Pediatr Infect Dis J 1998;17: 377-81.
3. Horn DL, Zabriskie JB, Austrian R, et al. Why have group A streptococci remained susceptible to penicillin? Report on a symposium. Clin Infect Dis 1997;26:1341-5.
4. Bass JW, Weisse ME, Plymyer MR, et al. Decline of erythromycin resistance of group A beta-hemolytic streptococci in Japan: comparison with worldwide reports. Arch Pediatr Adolesc Med 1994;148:67-71.
5. Seppala H, Klaukka T, Lehtonen R, et al. Outpatient use of erythromycin: link to increased erythromycin resistance in group A streptococci. Clin Infect Dis 1995;21:1378-85.
6. Seppala H, Klaukka T, Vuopio-Varkila J, et al. The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland: Finnish Study Group for Antimicrobial Resistance. N Engl J Med 1997;337:441-6.
7. Coonan K, Kaplan E. In vitro susceptibility of recent North American group A streptococcal isolates to eleven oral antibiotics. Pediatr Infect Dis J 1994;13:630-5.
8. Cornaglia G, Ligozzi M, Mazzariol A, et al. Resistance of Streptococcus pyogenes to erythromycin and related antibiotics in Italy: The Italian Surveillance Group for Antimicrobial Resistance. Clin Infect Dis 1998;27(Suppl 1):S87-92.
9. Baquero F, Garcia-Rodriguez JA, de Lomas JG, Aguilar L. Antimicrobial resistance of 914 beta-hemolytic streptococci isolated from pharyngeal swabs in Spain: results of a 1-year (1996-1997) multicenter surveillance study: The Spanish Surveillance Group for Respiratory Pathogens. Antimicrob Agents Chemother 1999;43:178-80.
10. Hong T, Ndamukong J, Millett W, et al. Direct application of Etest to Gram-positive cocci from blood cultures: quick and reliable minimum inhibitory concentration data. Diagn Microbiol Infect Dis 1996;25:21-5.
11. Hsueh PR, Teng LJ, Lee PI, et al. Outbreak of scarlet fever at a hospital day care centre: analysis of strain relatedness with phenotypic and genotypic characteristics. J Hosp Infect 1997; 36:191-200.
12. Kriebernegg I, Feierl G, Grisold A, Marth E. In-vitro susceptibility of group A beta-haemolytic streptococci (GABHS) to penicillin, erythromycin, clarithromycin and azithromycin in Styria, Austria. Zentralbl Bakteriol 1998;287:33-9.
13. Renneberg J, Niemann LL, Gutschik E. Antimicrobial susceptibility of 278 streptococcal blood isolates to seven antimicrobial agents. J Antimicrob Chemother 1997;39:135-40.
14. Sakran W, Raz R, Colodner R, Keness Y. Isolated susceptibility of Streptococcus pyogenes to 3 macrolides. Harefuah 1997;133:365-6, 414.
15. Thornsberry C, Yee YC. Comparative activity of eight antimicrobial agents against clinical bacterial isolates from the United States, measured by two methods. Am J Med 1996; 100:26S-38S.
16. Van Asselt GJ, Sloos JH, Mouton RP, et al. Susceptibility of Streptococcus pyogenes to azithromycin, clarithromycin, erythromycin and roxithromycin in vitro. J Med Microbiol 1995;43:386-91.
17. Johnson D, Stevens D, Kaplan E. Epidemiologic analysis of group A streptococcal serotypes associated with severe systemic infections, rheumatic fever, or uncomplicated pharyngitis. J Infect Dis 1992;166:374-82.
18. Johnson D, Kaplan E. A review of the correlation of T-agglutination patterns and M-protein typing and opacity factor production in the identification of group A streptococci. J Med Microbiol 1993;38:311-15.
19. Etest MIC determination of antibiotics. Piscataway, NJ: AB BIODISK North America, 1997.
20. Jorgensen JH, Ferraro MJ, Craig WA, et al. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. 4th ed. Approved Standard. NCCLS Document M7-A4. Wayne, PA: National Committee for Clinical Laboratory Standards, 1997.
21. Cocuzza C, Blandino G, Mattina R, et al. Antibiotic susceptibility of group A streptococci in 2 Italian cities: Milano and Catania. Microb Drug Resist 1997;3:379-84.
22. York MK, Gibbs L, Perdreau-Remington F, Brooks GF. Characterization of antimicrobial resistance in Streptococcus pyogenes isolates from the San Francisco Bay Area of Northern California. J Clin Microbiol 1999;37:1727-31.